project id: TCGA-BLCA; case submitter id: TCGA-GC-A3RD; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.2; rna integrity number: 8.2; age at index: 83; days to birth: -30529; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1928; age at diagnosis: 30529; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 428.0; icd 10 code: C67.0; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Trigone of bladder; synchronous malignancy: No; tissue or organ of origin: Trigone of bladder; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 70.0; portion submitter id: TCGA-GC-A3RD-01A-12; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 90.0;